News Releases

email   print   rss   

RSS Feeds

Quest Diagnostics Completes Acquisition of MedXM
Transaction expands Quest’s scale and reach in the mobile provider segment and bolsters its extended care capabilities

SECAUCUS, N.J. — February 1, 2018 — Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services.

The acquisition will strengthen Quest's mobile provider capabilities and population health management solutions for health plans. It will also bolster the company’s Extended Care services, which help health plans and providers better assess their populations and close gaps in care, with a focus on connecting with patients by phone, in homes and retail stores and other convenient settings.

Financial terms of the agreement were not disclosed. 

About Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Quest Contacts

Kim Gorode (Media): 973-520-2800

Shawn Bevec (Investors): 973-520-2900